Medical cannabis research and policy news in Europe
The short version: A tesamorelin 10mg vial contains 10mg of lyophilised peptide powder. The concentration of the reconstituted solution depends on the volume of diluent added. Adding 1ml…
Straight Answer: Cannabis dispensary marketing in Canada requires a specialized approach that balances local visibility with strict Health Canada compliance. Client Verge helps dispensaries attract local customers, build…
A study of dispensaries ranking in the top 20 of the local finder across the 24 largest legal-recreational US cities found 29 different primary categories in use on…
SEO for cannabis is one of those marketing categories where the industry’s underlying growth trajectory should shape strategy more than it usually does. U.S. legal cannabis sales now…
TRE House Delta 9 gummies are hemp-derived THC gummies with 10mg of delta-9 per piece, sold in several fruit flavors, with a popular 1:1 Peach Pear version that…
The short version: Bud Shack and Bear’s Den Cannabis are both Indigenous-owned dispensaries in the Oka-Kanesatake area, and both are genuinely good at different things. Bud Shack wins…
Over the past decade, few areas of healthcare have evolved as rapidly as cannabis-based medicine. Across Europe, healthcare professionals, researchers, pharmaceutical companies, regulators, and patients have become increasingly…
Medical cannabis has moved from the margins of healthcare discussion to the center of some of the most important debates in modern medicine. Across Europe, researchers, physicians, pharmaceutical…
An independent publication on medical cannabis research and regulation in Europe. We are not a pharmacy and do not sell products.
Educational content only — not medical or legal advice. We do not sell or supply any substance. Laws vary by country.
© 2026 Ganja Pharma EU. All rights reserved.